The trademark application ONYDA XR was filed by Tris Pharma, Inc., a U.S. corporation (the "Applicant"). Application under examination.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 5 with PHARMACEUTICAL PREPARATIONS WHICH ACT ON THE CENTRAL NERVOUS SYSTEM, INCLUDING MODIFIED RELEASE AND/OR EXTENDED RELEASE COMPOSITIONS CONTAINING CLONIDINE and PHARMACEUTICAL PREPARATIONS FOR TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER, INCLUDING MODIFIED RELEASE AND/OR EXTENDED RELEASE COMPOSITIONS CONTAINING CLONIDIN..